Ryan Confer Discusses Genprex’s Future in Diabetes and Oncology NASDAQ: GNPX
In an in-depth conversation with Ryan Confer, CEO of Genprex (GNPX), we explored the company’s dynamic pipeline, including lead candidates like Reqorsa® Gene Therapy for lung cancer and GPX-002 for…